Hunter Cancer Research Symposium 2017
Friday, 24 November 2017, 08:30 am — Friday, 24 November 2017, 06:00 pm
|Location||Hunter Medical Research Institute, Kookaburra Circuit, New Lambton Heights|
The Hunter Cancer Research Alliance welcomes all cancer-focused researchers, students & clinicians to the annual Hunter Cancer Research Symposium to be held on Friday, 24th November 2017.
The Symposium brings together cancer researchers and clinicians working across basic science, clinical research, clinical practice, public health and health services research.
The keynote speakers for this event, Professor Barry Bultz and Professor Susan Clark, are leaders in their respective fields and we are delighted to welcome them to Newcastle for this event.
Barry D. Bultz, PhD, holds the Daniel Family Leadership Chair in Psychosocial Oncology and is Professor and Head, Division of Psychosocial Oncology, Cumming School of Medicine at the University of Calgary.
He is Director, Department of Psychosocial and Rehabilitation Oncology; Tom Baker Cancer Centre in Calgary. Dr. Bultz is a co-founder and Past President of the Canadian Association of Psychosocial Oncology (CAPO). He served as an Invited Director of the Board of the American Psychosocial Oncology Society. From 2012 to 2014, Dr. Bultz served as President of the International Psycho-Oncology Society.
He advocates for the recognition of the impact of cancer-related distress (6th Vital Sign) on patient experience and has published and presents frequently on the importance of screening and management of distress. His work with cancer patients has seen him receive many awards, including the Queen's Diamond Jubilee Award, the Alberta Order of Excellence in 2016, and the Arthur Sutherland Award from the International Psycho-Oncology Society in 2016. In February 2017 he was elected Fellow of the American Psychosocial Oncology Society-the first for a non-American.
Professor Susan Clark, FAA has a highly acclaimed international reputation for her work in cancer epigenetics. Susan is a NHMRC Senior Principal Research Fellow and Head of the Genome and Epigenetics Division at the Garvan Institute of Medical Research in Sydney, Australia. She graduated in 1982 with a PhD in Biochemistry, University of Adelaide.
Her molecular studies over her career have addressed profound questions about the importance of epigenetics in early development and in disease, especially in cancer. The techniques she pioneered in the early 1990s, including bisulphite methylation sequencing, helped to revolutionise epigenomic research. Susan was a founding member of IHEC (International Human Epigenome Consortium) and led the formation of the AEpiA (Australian Epigenetics Alliance).
She has a number of awards including the RPAH Research Medal (2002), Julian Wells Medal (2003); “Biochemisch Analytik Preis” for outstanding contribution for Methylation analysis in 2004; In 2006 was elected a Fellow of the World Technology Network for Biotechnology, 2012 was awarded the National Rotary Vocational Award and in 2015 was elected a Fellow of the Australian Academy of Science and received the NSW Cancer Institute “Make a Difference” Award and the Nadine Watson Annual Lecture Award.
HCRA members are warmly invited to submit an abstract, from any area of translational cancer research, for oral and poster presentations at this symposium.
Abstracts selected for presentation will be published online, as a supplement to the Asia-Pacific Journal of Clinical Oncology.
- maximum abstract length is 300 words (including sub-headings)
- abstracts are should be submitted via this online form
- abstracts must be submitted by Friday 4th August 2017
- all abstracts will be peer-reviewed as part of the selection process
- there will be awards for the best oral and poster presentations at the Symposium, with special categories for ECR & student presentations.
Please direct any enquiries to HCRA@newcastle.edu.au or phone 02 4014 4753.